Here, researchers began by examining gene activity in cancer-fighting T cells ... which can serve as a long-term source of cytotoxic CD8+ T cells. This enzyme had also been identified in prior ...
The researchers then systematically blocked the activity of individual metabolic ... of more mature tumor-fighters called cytotoxic CD8 + T cells. This enzyme had also been identified in prior ...
Equillium Inc. (Nasdaq: EQ), a clinical-stage biotechnology company leveraging a deep understanding of immunobiology to develop novel therapeutics to ...
A second CAR T-cell expansion started day on 39 but consisted of multiple CAR+ populations. Two CAR+ populations were characterized by CD4+ or CD8+ expression, and one population was negative for ...